Product Information
CYCLOBENZAPRINE 7.5 MG TABLET is a generic product labeled by TruPharma LLC, priced at $0.3553 per EA under NDC 52817033110. Its NADAC has been published 353 times since Jun 6, 2018.
FDA first approved this application on May 31, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
TruPharma LLCNDC
52817033110
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208170FDA Approved
5/31/2017
TE Code
AB
On Market Since
5/31/2017
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has been published 353 times since Jun 6, 2018, and over the history we have for it it has declined 86.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3553 per EA |
|---|---|
| All-time high | $2.9863 (Oct 10, 2018) |
| All-time low | $0.2771 (Dec 20, 2023) |
| Median price | $1.1070 |
| Average price | $1.0531 |
| Largest weekly change | -68.4% (Oct 19, 2022) |
| Weeks tracked | 353 |
| Tracking since | Jun 6, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+0.7%
5Y
-67.9%
All
-86.6%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 7.5 MG TABLET, manufactured by TruPharma LLC, is $0.3553 per EA (NDC 52817033110), effective Mar 5, 2025.
How has the price of CYCLOBENZAPRINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has declined 86.6%. It has been tracked across 353 weekly CMS publications since Jun 6, 2018.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 7.5 MG TABLET?
Since Jun 6, 2018, the NADAC for CYCLOBENZAPRINE 7.5 MG TABLET has ranged from a low of $0.2771 (Dec 20, 2023) to a high of $2.9863 (Oct 10, 2018), with a median of $1.1070 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 7.5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOBENZAPRINE 7.5 MG TABLET, is $0.2402 per EA — about 32% below CYCLOBENZAPRINE 7.5 MG TABLET.
Who manufactures CYCLOBENZAPRINE 7.5 MG TABLET?
CYCLOBENZAPRINE 7.5 MG TABLET (NDC 52817033110) is labeled by TruPharma LLC, and CMS classifies it as a generic product.